$EW News

Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?

Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?

Leerink Partners Upgrades Edwards Lifesciences (EW)

Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium

Edwards, The 'Cleanest Large-Cap Medtech Story,' Launches On Second-Quarter Beat

JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105

Edwards lifts FY26 growth outlook following steady Q2 performance

Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $101

Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion

Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ...

Edwards Lifesciences Q2 Earnings Call Highlights

Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Edwards Stock Launches As Heart-Valve Replacements Beat On

Edwards Lifesciences (NYSE:EW) Raises Guidance After Solid Q2 Earnings, Stock Surges 6%

Edwards Lifesciences Corporation (EW) Q2 2026 Earnings Call Transcript

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences Sees Q3 Adj EPS $0.71-$0.77 vs $0.74 Est; Sees Sales $1.630B-$1.710B vs $1.689B Est

Edwards Lifesciences Affirms FY2026 Adj EPS Guidance of $2.95-$3.05 vs $3.01 Est; Raises FY2026 Sales Guidance from $6.500B-$6.900B to $6.600B-$6.900B vs $6.745B Est